Related Experiment Videos
Biosensing of opioids using frog melanophores
Annika M Karlsson1, Katarina Bjuhr, Martin Testorf
1Department of Medicine and Care, Pharmacology, Faculty of Health Sciences, SE-581 85, Linkoping, Sweden.
Biosensors & Bioelectronics
|February 19, 2002
Summary
Recombinant frog melanophores engineered to express human opioid receptors serve as a novel biosensor for detecting opioids. This innovative approach utilizes pigment cell responses for sensitive and selective substance detection in biological samples.
Area of Science:
- Cell Biology
- Biotechnology
- Neuroscience
Background:
- Lower vertebrates exhibit color changes due to specialized pigment cells called chromatophores.
- Melanophores, a type of chromatophore containing melanin, show pigment aggregation or dispersion, which can be optically measured.
- Functional expression of G protein-coupled receptors in cultured melanophores offers potential for biosensing applications.
Purpose of the Study:
- To develop a novel biosensor for opioid detection using recombinant frog melanophores.
- To investigate the utility of engineered melanophores expressing human opioid receptors for substance detection.
Main Methods:
- Frog melanophores were transfected with the human opioid receptor 3.
- Opioid detection was performed using an aggregation assay analyzing absorbance changes.
- Receptor pharmacology was assessed via competitive inhibition studies with naloxone.
Main Results:
- Transfected melanophores exhibited pigment aggregation in response to opioid receptor agonists like morphine.
- The engineered melanophore biosensor demonstrated selective detection of opioids.
- The expressed receptor pharmacology closely mirrored its mammalian counterpart.
Conclusions:
- Recombinant frog melanophores can be effectively utilized as a biosensor for detecting opioids.
- This melanophore biosensor technology has potential for measuring various substances in body fluids.
- Engineered melanophores offer a versatile platform for developing selective biosensors.